在Bufo胆囊中的3α-Hydroxybufadienolides:结构见解和生物转化
Li-Jun Ruan1,2, Zhi-Jun Song2, Ren-Wang Jiang3
1State Key Laboratory of Bioactive Molecules and Draggability Assessment, College of Pharmacy, Jinan University, Guangzhou, 510632, China.
Natural products and bioprospecting
|March 4, 2024
概括
研究人员从的胆囊中鉴定出了21种bufadienolides,包括新的化合物. 他们在青中发现了一个关键的生物转化过程,即将3β-OH转化为3α-OH布法基化物以进行自我排毒.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 布法迪化物是天然存在的类固醇,在中发现,具有显著的药理和生态相关性.
- 布法迪化物具有不同的结构配置,特别是3α-OH和3β-OH同体,具有不同的生物发生和特性.
- 了解布法醇生物转化对于阐明它们的生态作用和潜在的药用应用至关重要.
研究的目的:
- 从Bufo gargarizans的胆囊中分离和识别bufadienolides. 为了分离和识别Bufo gargarizans的胆囊.
- 为了研究肝和脏组织中的3β-OH和3α-OH布法迪化物的生物转化途径.
- 探索布法迪埃诺利德结构多样性和代谢的生态和潜在的医学意义.
主要方法:
- 使用染色学和光谱技术分离和结构阐明布法迪化物.
- 在的胆汁和毒液中分析布法迪埃诺利德的配置.
- 在实验室生物转化试验中使用肝和脏组织同质化物.
主要成果:
- 分离了21种bufadienolides,包括4种新型化合物和17种已知的类似物.
- 在胆中观察到显著的3α-OH bufadienolides占主导地位,与毒中的3β-OH形式形成鲜明对比.
- 在肝和脏组织中证实了3β-OH的不可逆转生物转化为3α-OH布法迪化物.
结论:
- 这项研究揭示了Bufo gargarizans中的bufadienolides的结构多样性.
- 这些发现表明,3β-OH转化为3α-OH在的自我排毒机制中起着关键作用.
- 这项研究增强了对布法迪埃诺利德代谢的理解,有助于它们的医学和生态意义.
相关概念视频
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Hepatic Drug Excretion: Influencing Factors
129
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
129
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Phase II Reactions: Glucuronidation
420
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
420
Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K


